CTOs on the Move

Alkeus Pharmaceuticals, Inc.

www.alkeuspharma.com

 
Alkeus Pharmaceuticals, Inc. is a late-stage biopharmaceutical company developing transformative therapeutics to address serious, progressive eye diseases that lead to blindness. Our lead compound, ALK-001, is an oral investigational drug being developed for the treatment of Stargardt disease (STGD) and Geographic Atrophy (GA) secondary to dry age-related macular degeneration. ALK-001 is a selectively-deuterated form of Vitamin A that slows the dimerization of Vitamin A, which is implicated in STGD, and has shown statistically-significant and clinically-meaningful efficacy in the TEASE-1 Phase 2 clinical trial. Based on these results, ALK-001 has been granted Breakthrough Therapy Designation for the treatment of Stargardt Disease.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Extension Concepts

Extension Concepts is a Montreal, QC-based company in the Business Services sector.

Walter E Nelson Co

Walter E Nelson Co is a Portland, OR-based company in the Business Services sector.

Money Mailer, LLC

Money Mailer, LLC is one of the leading providers in Business Services. It is based in Garden Grove, CA. To find more information about Money Mailer, LLC, please visit www.moneymailer.com.

Teseq

Teseq is a Edison, NJ-based company in the Business Services sector.

new england art publishers inc

new england art publishers inc is a Abington, MA-based company in the Business Services sector.